Visualization techniques, structure-activity

Poly-C-SpecificRibonuclease (P-RNase) (EC3.1.27.5). Warshawand Fournier (W3) showed that an increase in plasma enzyme activity of pancreatic P-RNase in patients with AP may indicate necrotic lesions, and is one of the few direct markers of pancreatic tissue injury (Nl, W4). Due to the time-consuming and cumbersome nature of the P-RNase assay procedure and the development of effective visualization techniques providing direct information on the structure of the inflamed pancreas, the diagnostic utility of the P-RNase assay has not been extensively studied (Table 3). 

These pharmacophore techniques are different in format from the traditional pharmacophore definitions. They can not be easily visualized and mapped to the molecular structures rather, they are encoded as keys or topological/topographical descriptors. Nonetheless, they capture the same idea as the classic pharmacophore concept. Furthermore, this formalism is quite useful in building quantitative predictive models that can be used to classify and predict biological activities. 

Those readers who are unfamiliar with esoteric work may be bewildered by the use of detailed visualization in both the practical applications of Alchemy and of Vajrayana. The ancient science of visualization is foreign to our modern mental structures, yet we use it in fantasy every day. However, the theory and practice of visualization has been confirmed by research and the discoveries of depth psychology. It is a technique of self-knowledge and of the re-integration of forces that are active in our subconscious. It is, above all, a direct support for the process of Liberation. 

Because the 2570 A band of phenylalanine is weak, it is often obscured in proteins by the much stronger tyrosine and tryptophan absorptions. It is occasionally visualized in protein spectra as ripples (fine structure) in the spectral region 2500-2700 A. These ripples can be amplified by the difference spectral technique, as is shown in Fig. 13. A typical phenylalanine difference spectrum, obtained in a comparison of the isoelectric amino acid with a solution of the same concentration at pH 1 is shown in Fig. 12. Difference spectra for phenylalanine in various solvents have been measured by Bigelow and Geschwind (1960), Yanari and Bovey (1960), and Donovan et al. (1961). Fluorescence activation and emission spectra for phenylalanine were measured by Teale and Weber (1957). 

---